India, March 31 -- Could you share some of 2024's most impactful milestones for RNT Health Insights and key plans for 2025?

During 2024, RNT Health Insights achieved significant milestones, including receiving the US FDA Breakthrough Device Designation for two of our Medical Devices- one intended for Early Gastric Cancer detection and the other for detecting Early-stage Oesophageal Cancer. Oesophageal cancer is the fourth leading cause of cancer-related deaths in India and the sixth leading cause of cancer-related deaths worldwide, claiming over 540,000 lives annually. Its prognosis is notably poor, with a five-year survival rate of less than 20 per cent. This is primarily due to the associated high miss rate of detection during early st...